Chapter/Section Purchase

1 Study Coverage
1.1 Circulating Biomarker for Liquid Biopsy Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Circulating Biomarker for Liquid Biopsy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size for the Year 2017-2028
1.2.2 Global Circulating Biomarker for Liquid Biopsy Market Size for the Year 2017-2028
1.3 Circulating Biomarker for Liquid Biopsy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Circulating Biomarker for Liquid Biopsy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Circulating Biomarker for Liquid Biopsy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Circulating Biomarker for Liquid Biopsy Market Dynamics
1.4.1 Circulating Biomarker for Liquid Biopsy Industry Trends
1.4.2 Circulating Biomarker for Liquid Biopsy Market Drivers
1.4.3 Circulating Biomarker for Liquid Biopsy Market Challenges
1.4.4 Circulating Biomarker for Liquid Biopsy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Circulating Biomarker for Liquid Biopsy by Type
2.1 Circulating Biomarker for Liquid Biopsy Market Segment by Type
2.1.1 Circulating Tumor Cells (CTCs)
2.1.2 Circulating Tumor DNA (ctDNA)
2.1.3 Cell-Free DNA (cfDNA)
2.1.4 Extracellular Vesicles (EVs)
2.1.5 Others
2.2 Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2017, 2022 & 2028)
2.3 Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2028)
2.4 United States Circulating Biomarker for Liquid Biopsy Market Size by Type (2017, 2022 & 2028)
2.5 United States Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2028)
3 Circulating Biomarker for Liquid Biopsy by Application
3.1 Circulating Biomarker for Liquid Biopsy Market Segment by Application
3.1.1 Early Cancer Screening
3.1.2 Therapy Selection
3.1.3 Treatment Monitoring
3.1.4 Recurrence Monitoring Orthopedics
3.2 Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2017, 2022 & 2028)
3.3 Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2028)
3.4 United States Circulating Biomarker for Liquid Biopsy Market Size by Application (2017, 2022 & 2028)
3.5 United States Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2028)
4 Global Circulating Biomarker for Liquid Biopsy Competitor Landscape by Company
4.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Company
4.1.1 Top Global Circulating Biomarker for Liquid Biopsy Companies Ranked by Revenue (2021)
4.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue by Player (2017-2022)
4.2 Global Circulating Biomarker for Liquid Biopsy Concentration Ratio (CR)
4.2.1 Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Circulating Biomarker for Liquid Biopsy in 2021
4.2.3 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Circulating Biomarker for Liquid Biopsy Headquarters, Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Circulating Biomarker for Liquid Biopsy Headquarters and Area Served
4.3.2 Global Circulating Biomarker for Liquid Biopsy Companies Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Circulating Biomarker for Liquid Biopsy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Circulating Biomarker for Liquid Biopsy Market Size by Company
4.5.1 Top Circulating Biomarker for Liquid Biopsy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Circulating Biomarker for Liquid Biopsy Revenue by Players (2020, 2021 & 2022)
5 Global Circulating Biomarker for Liquid Biopsy Market Size by Region
5.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2028)
5.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Region: 2017-2022
5.2.2 Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2017-2028
6.1.2 North America Circulating Biomarker for Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2017-2028
6.3.2 Europe Circulating Biomarker for Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2017-2028
6.4.2 Latin America Circulating Biomarker for Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Details
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction
7.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.1.5 Abbott Laboratories Recent Development
7.2 Becton, Dickinson and Company
7.2.1 Becton, Dickinson and Company Company Details
7.2.2 Becton, Dickinson and Company Business Overview
7.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction
7.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.2.5 Becton, Dickinson and Company Recent Development
7.3 GE Healthcare
7.3.1 GE Healthcare Company Details
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction
7.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.3.5 GE Healthcare Recent Development
7.4 Epigenomics AG
7.4.1 Epigenomics AG Company Details
7.4.2 Epigenomics AG Business Overview
7.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction
7.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.4.5 Epigenomics AG Recent Development
7.5 Agilent Technologies
7.5.1 Agilent Technologies Company Details
7.5.2 Agilent Technologies Business Overview
7.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction
7.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.5.5 Agilent Technologies Recent Development
7.6 Biocept
7.6.1 Biocept Company Details
7.6.2 Biocept Business Overview
7.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction
7.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.6.5 Biocept Recent Development
7.7 Affymetrix
7.7.1 Affymetrix Company Details
7.7.2 Affymetrix Business Overview
7.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction
7.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.7.5 Affymetrix Recent Development
7.8 Fluxion Biosciences
7.8.1 Fluxion Biosciences Company Details
7.8.2 Fluxion Biosciences Business Overview
7.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction
7.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
7.8.5 Fluxion Biosciences Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer